Majhi AK

No ORCID on file · 4 papers in corpus · active 2011-2025

Study types

  • rct 2
  • article 1
  • review 1

Condition tags

  • adenomyosis 3
  • endometriosis 2
  • infertility 2
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • endometrioma 1
rct 2025
Comparative analysis of low-dose letrozole versus GnRH agonist on implantation markers and IVF outcomes in symptomatic adenomyosis: a randomized trial
Scientific reports ·doi:10.1038/s41598-025-32974-z

Symptomatic adenomyosis is a known impediment to successful implantation and pregnancy in in vitro fertilization; yet optimal pre-treatment strategic approach remains uncertain. This randomized controlled trial compared the effects of low d…

article 2025
Impact of Localization of Diffuse Adenomyosis on Frozen Embryo Transfer Outcomes and Perinatal Outcomes: A Prospective Cohort Study of 585 Patients
Gynecologic and obstetric investigation ·doi:10.1159/000546437

OBJECTIVE: The objective of this study was to investigate the impact of localization of diffuse adenomyosis on reproductive outcomes after frozen embryo transfer (FET). DESIGN: This prospective cohort study was conducted between January 20…

rct 2023
Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.03.010

RESEARCH QUESTION: Can low-dose letrozole reduce dysmenorrhoea, menorrhagia and sonographic features in symptomatic women with adenomyosis awaiting IVF? DESIGN: This was a longitudinal randomized prospective pilot study to explore the effe…

review 2011
Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.05.021

OBJECTIVE: To determine the role of the aromatase inhibitor letrozole in the treatment of recurrent ovarian endometrioma cases. DESIGN: Nonrandomized proof of concept study. SETTINGS: Outpatient tertiary-care center. PATIENT(S): Five pre…